"The general toxicology, DART, and pathology groups at
MPI Research went above and beyond our needs and
helped us obtain IND approval for our HPV therapeutic
vaccine. This approval would not have been achieved
without the knowledge and dedication of the MPI Research
staff. It is rewarding to partner with a company that is
dedicated to improve the overall health of our world."
KinKai Hwang, PhD
Chief Scientific Officer, HealthBanks Biotech USA Inc.